TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue — influence of BMI and adipose distribution

Abstract

Tumour necrosis factor (TNF)α is implicated in the relationship between obesity and insulin resistance/type 2 diabetes. In an effort to understand this association better we (i) profiled gene expression patterns of TNF, TNFR1 and TNFR2 and (ii) investigated the effects of TNF on glucose uptake in isolated adipocytes and adipose tissue explants from omental and subcutaneous depots from lean, overweight and obese individuals.

TNF expression correlated with expression of TNFR2, but not TNFR1, and TNF and TNFR2 expression increased in obesity. TNFR1 expression was higher in omental than in subcutaneous adipocytes. Expression levels of TNF or either receptor did not differ between adipocytes from individuals with central and peripheral obesity. TNF only suppressed glucose uptake in insulin-stimulated subcutaneous tissue and this suppression was only observed in tissue from lean subjects.

These data support a relationship between the TNF system and body mass index (BMI), but not fat distribution, and suggest depot specificity of the TNF effect on glucose uptake. Furthermore, adipose tissue from obese subjects already appears insulin ‘resistant’ and this may be a result of the increased TNF levels.

Keywords

TNFα TNF receptors adipose tissue human insulin resistance obesity

References

1. Ledgerwood EC , Prins JB. Tumour necrosis factor alpha. in: Marshall SM , Home PD , Rizza R , Eds. Diabetes Annual/12. Elsevier: Oxford, 1998, 161–80.

2. Uysal KT , Wiesbrock SM , Marino MW , Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997;389:610–14.

3. Hauner H , Petruschke T , Russ M , Rohrig K , Eckel J. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 1995;38:764–71.

4. Stephens JM , Lee J , Pilch PF. Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997;272:971–6.

5. Hotamisligil GS , Peraldi P , Budavari A , Ellis R , White MF , Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996;271:665–8.

6. Kern PA , Saghizadeh M , Ong JM , Bosch RJ , Deem R , Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111–19.

7. Tsigos C , Kyrou I , Chala E et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999;48:1332–5.

8. Petruschke T , Hauner H. Tumor necrosis factor-alpha prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 1993;76:742–7.

9. Grunfeld C , Zhao C , Fuller J et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152–7.

10.

10. Zhang HH , Halbleib M , Ahmad F , Manganiello VC , Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes 2002;51:2929–35.

11.

11. Prins JB , Niesler CU , Winterford CM et al. Tumor necrosis factor-alpha induces apoptosis of human adipose cells. Diabetes 1997;46:1939–44.

12.

12. Warne JP. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol 2003;177:351–5.

13.

13. Hotamisligil GS , Budavari A , Murray D , Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994;94:1543–9.

14.

14. Hube F , Hauner H. The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipocytes in primary culture. Endocrinology 2000;141:2582–8.

15.

15. Hotamisligil GS , Shargill NS , Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87–91.

16.

16. Ofei F , Hurel S , Newkirk J , Sopwith M , Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996;45:881–5.

17.

17. Bazzoni F , Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717–25.

18.

18. Xu H , Uysal KT , Becherer JD , Arner P , Hotamisligil GS. Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes 2002;51:1876–83.

19.

19. Hotamisligil GS , Arner P , Atkinson RL , Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997;46:451–5.

20.

20. Hube F , Birgel M , Lee YM , Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999;29:672–8.

21.

21. Peraldi P , Hotamisligil GS , Buurman WA , White MF , Spiegelman BM. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem 1996;271:13018–22.

22.

22. Weisberg SP , McCann D , Desai M , Rosenbaum M , Leibel RL , Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796–808.

23.

23. Fernandez-Real JM , Broch M , Vendrell J , Ricart W. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Int J Obes Relat Metab Disord 2003;27:1552–6.

24.

24. You T , Ryan AS , Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. J Clin Endocrinol Metab 2004;89:5517–22.

25.

25. Maeda N , Shimomura I , Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731–7.

26.

26. Wang B , Jenkins JR , Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: integrated response to TNF-alpha. Am J Physiol Endocrinol Metab 2005;288:E731–E740.

27.

27. Souza SC , Yamamoto MT , Franciosa MD , Lien P , Greenberg AS. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones. Diabetes 1998;47:691–5.

28.

28. Prins JB , Walker NI , Winterford CM , Cameron DP. Human adipocyte apoptosis occurs in malignancy. Biochem Biophys Res Commun 1994;205:625–30.

29.

29. Hutley LJ , Newell FM , Joyner JM et al. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest 2003;33:574–81.

30.

30. Chomczynski P , Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–9.

31.

31. Stolic M , Russell A , Hutley L et al. Glucose uptake and insulin action in human adipose tissue — influence of BMI, anatomical depot and body fat distribution. Int J Obes Relat Metab Disord 2002;26:17–23.

32.

32. Niesler CU , Siddle K , Prins JB. Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes 1998;47:1365–8.

33.

33. Arner P. Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001;29:72–5.

34.

34. Montague CT , Prins JB , Sanders L et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998;47:1384–91.

35.

35. Dusserre E , Moulin P , Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000;1500:88–96.

36.

36. Curat CA , Miranville A , Sengenes C et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004;53:1285–92.

37.

37. Niesler CU , Prins JB , O'Rahilly S , Siddle K , Montague CT. Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNF alpha. Int J Obes Relat Metab Disord 2001;25:1027–33.

38.

38. Dandona P , Weinstock R , Thusu K , Abdel-Rahman E , Aljada A , Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998;83:2907–10.

39.

39. Maachi M , Pieroni L , Bruckert E et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004;28:993–7.

40.

40. Xu H , Hirosumi J , Uysal KT , Guler AD , Hotamisligil GS. Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 2002;143:1502–11.